Literature DB >> 16230590

Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer.

Mark El-Deiry1, Gerry F Funk, Sarvi Nalwa, Lucy H Karnell, Russell B Smith, John M Buatti, Henry T Hoffman, Gerry H Clamon, Scott M Graham, Douglas K Trask, Kenneth J Dornfeld, Min Yao.   

Abstract

OBJECTIVE: To compare the long-term, health-related quality-of-life outcomes in patients with advanced head and neck cancer (HNC) treated with surgery and postoperative radiation therapy (SRT) or concurrent chemotherapy and radiation therapy (CRT).
DESIGN: Matched-pair study comparing patients with advanced HNC treated with SRT or CRT at least 12 months after treatment. Patients completed 2 validated surveys addressing HNC-specific outcomes and depressive symptoms and provided information on employment and tobacco and alcohol use. Results for the 2 groups were compared using paired-sample t test and chi2 analysis.
SETTING: University-based study. PATIENTS: Patients with stage III or IV squamous cell carcinoma of the oropharynx, hypopharynx, and larynx who underwent SRT or received CRT. MAIN OUTCOME MEASURES: Head and neck cancer-specific health-related quality of life from the Head and Neck Cancer Inventory and level of depressive symptoms from the Beck Depression Inventory.
RESULTS: The matching process resulted in 27 patients in each treatment group. The HNC-specific domain scores (with higher scores representing better outcomes) for CRT vs SRT were eating, 37.8 vs 40.8 (P = .69); speech, 65.1 vs 56.0 (P = .23); aesthetics, 80.3 vs 69.2 (P = .14); and social disruption, 69.7 vs 70.6 (P = .90). Overall health-related quality of life was 64.0 with SRT and 55.0 with CRT (P = .142). For the Beck Depression Inventory (with higher scores representing worse outcomes), patients who underwent SRT had a mean score of 9.6 compared with 11.6 for patients who received CRT (P = .42).
CONCLUSION: As nonsurgical means of treating HNC have become more aggressive and surgical techniques have become more focused on function preservation and rehabilitation, the overall health-related quality of life resulting from these different approaches is similar.

Entities:  

Mesh:

Year:  2005        PMID: 16230590     DOI: 10.1001/archotol.131.10.879

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  27 in total

1.  [Transoral resection of locally advanced squamous cell carcinoma of the side wall of the oropharynx: multimodal treatment concepts in transition].

Authors:  C Simon; P K Plinkert
Journal:  HNO       Date:  2006-08       Impact factor: 1.284

2.  Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.

Authors:  I Hwang; S H Choi; Y-J Kim; K G Kim; A L Lee; T J Yun; J-h Kim; C-H Sohn
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

3.  Outcomes of transoral robotic surgery: a preliminary clinical experience.

Authors:  Agnes Hurtuk; Amit Agrawal; Matthew Old; Theodoros N Teknos; Enver Ozer
Journal:  Otolaryngol Head Neck Surg       Date:  2011-08       Impact factor: 3.497

Review 4.  Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.

Authors:  Sungheon Gene Kim; Kent Friedman; Sohil Patel; Mari Hagiwara
Journal:  AJR Am J Roentgenol       Date:  2016-05-10       Impact factor: 3.959

5.  Quality-of-life outcomes in transoral robotic surgery.

Authors:  Agnes M Hurtuk; Anna Marcinow; Amit Agrawal; Matthew Old; Theodoros N Teknos; Enver Ozer
Journal:  Otolaryngol Head Neck Surg       Date:  2011-08-31       Impact factor: 3.497

6.  Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q Head and Neck Cancer Module.

Authors:  Jennifer R Cracchiolo; Anne F Klassen; Danny A Young-Afat; Claudia R Albornoz; Stefan J Cano; Snehal G Patel; Andrea L Pusic; Evan Matros
Journal:  Cancer       Date:  2018-11-30       Impact factor: 6.860

Review 7.  Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.

Authors:  Ari J Rosenberg; Everett E Vokes
Journal:  Oncologist       Date:  2020-09-21

8.  Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.

Authors:  Sungheon Kim; Laurie Loevner; Harry Quon; Eric Sherman; Gregory Weinstein; Alex Kilger; Harish Poptani
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

Review 9.  Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review.

Authors:  Lisette van der Molen; Maya A van Rossum; Lori M Burkhead; Ludi E Smeele; Frans J M Hilgers
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-30       Impact factor: 2.503

10.  Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy.

Authors:  Ken Dornfeld; Shane Hopkins; Joel Simmons; Douglas R Spitz; Yusuf Menda; Michael Graham; Russell Smith; Gerry Funk; Lucy Karnell; Michael Karnell; Maude Dornfeld; Min Yao; John Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.